A carregar...

Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives

Currently, two direct-acting antivirals (DAAs) show well-established efficacy against hepatitis C virus (HCV), namely, first-wave protease inhibitors telaprevir and boceprevir. Most clinical trials have examined DAAs in combination with standard of care (SOC) regimens. Future therapeutic drugs were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hee Bok Chae, Seon Mee Park, Sei Jin Youn
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Limited 2013-01-01
Colecção:The Scientific World Journal
Acesso em linha:http://dx.doi.org/10.1155/2013/704912
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!